Analysis of InsuLine Medical Ltd. Reports Significant Initial Results In A Clinical Feasibility Study Which Tested The Impact Of Local Treatments On Basal Insulin (Long Acting Insulin) - aVenture Research
BioSpace
InsuLine Medical Ltd. Reports Significant Initial Results In A Clinical Feasibility Study Which Tested The Impact Of Local Treatments On Basal Insulin (Long Acting Insulin)
Insuline Medical (TASE: INSL.TA), A medical device research, development and marketing company of injection site treatment and stabilization technologies (ISTS) in order to improve the effectiveness of subcutaneously delivered drugs, announced a significant initial results in a clinical feasibility study with regard to the procedures completed so far. The aim of the study was to test the impact of local treatments at the injection site of long acting insulin (insulin glargine) on insulin levels